Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director
Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective February 19, 2018
Mr. Walt joins Quotient’s board of directors with over 29 years of experience in leadership roles at two of the largest, most influential healthcare companies, Siemens Healthineers and Roche, and serves as an expert advisor on the in-vitro diagnostics industry to manufacturing companies and private equity firms. His career has focused on business turnaround and market expansion, emphasising innovation, strategic alliances, quality and commercialisation.
To read the full article, click here.